GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFUL.L Regulatory News (FUL)

  • There is currently no data for FUL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Collaboration with Quantum Solutions

14 Nov 2008 07:00

RNS Number : 1344I
Fulcrum Pharma PLC
14 November 2008
 



FULCRUM PHARMA PLC 

Fulcrum Pharma and Quantum Solutions India form strategic collaboration to deliver high quality, high capacity drug safety services 

Fulcrum Pharma plc (AIM: FUL), the Professional Services company is pleased to announce a strategic collaboration with Quantum Solutions India in the field of drug safety. 

Fulcrum Pharma is committed to providing clients with expert solutions in pharmacovigilance for both pre- and post-marketed products. The collaboration brings together Fulcrum Pharma's expertise in strategic and operational pharmacovigilance and Quantum's expertise in delivering high quality ICSR and PSUR processing. 

The two companies will offer creative pharmacovigilance solutions in a cost-effective and tailored approach to new and existing clients. Quantum and Fulcrum Pharma believe that together they are positioned to deliver effective safety solutions to clients using a cost-leadership model coupled with excellence in execution and a proven track record in quality & compliance. 

Under the terms of the collaboration the companies will pool expertise and resources and establish a joint sales and marketing campaign in Europe and North America. Both companies, however, remain legally and operationally independent. 

Speaking of the newly forged strategic collaboration, Frank Armstrong, Chief Executive of Fulcrum Pharma, said: "Together we will be in a position to meet the increasing demand for pharmacovigilance services. The collaboration with Quantum will increase our capacity to deliver key safety products to our clients and enhance the reach of our business. We look forward to working together to develop solutions for our clients." 

Apurva Goswamy, Chief Executive of Quantum Solutions, said. "This collaboration will provide tailored solutions to meet our customers' needs, combining the strategic and operational skills of Fulcrum Pharma with the operational expertise of Quantum Solutions. Working with Fulcrum Pharma will enable us to enhance our drug safety product offering in a way that directly benefits our clients. This is an exciting opportunity for both Quantum and Fulcrum" 

For further information, please contact: 

Fulcrum Pharma PLC

Dr Frank M. Armstrong, Chief Executive  Tel: 01442 283600

Dr Phil Birch, General Manager (Europe) Tel: 01442 283600

About Fulcrum Pharma plc 

Fulcrum Pharma plc is a professional services company providing clients with expert solutions for the development of therapeutic products. Fulcrum Pharma is listed on the AIM Market of the London Stock Exchange having successfully floated in March 2000. 

About Quantum Solutions India

Quantum Solutions India is a highly-reputed quality-driven contract research organization serving the pharmaceutical industry, and specializing in drug safety. Its highly qualified, professional, English-speaking staff supported by a robust IT infrastructure ensure very high standards of service delivery.

___________________________

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAILFEELVLVLIT
Date   Source Headline
4th Oct 20215:47 pmRNSExercise of Options and Total Voting Rights
4th Oct 20211:10 pmRNSExercise of Options and Total Voting Rights
30th Sep 20212:45 pmRNSTotal Voting Rights
29th Sep 20215:55 pmRNSResult of AGM
29th Sep 20217:00 amRNSAGM Statement
24th Sep 20214:05 pmRNSResults of Placing
24th Sep 20213:00 pmRNSExercise of Options and Proposed Secondary Placing
16th Sep 20215:57 pmRNSExercise of Options and Total Voting Rights
14th Sep 20217:00 amRNSExercise of Options and Total Voting Rights
10th Sep 20215:24 pmRNSExercise of Options and Total Voting Rights
7th Sep 20217:00 amRNSNotice of Annual General Meeting
2nd Sep 20212:41 pmRNSExercise of Options and Total Voting Rights
1st Sep 20215:01 pmRNSTotal Voting Rights
27th Aug 20219:50 amRNSDirector/PDMR Shareholding
26th Aug 20217:00 amRNSExercise of Options and Total Voting Rights
17th Aug 20217:00 amRNSFinal Results
5th Aug 20217:00 amRNSChange of Nomad and Broker
28th May 20217:00 amRNSTrading Update
30th Apr 20215:00 pmRNSTotal Voting Rights
23rd Apr 20213:30 pmRNSGrant & exercise of options and TVR
23rd Apr 20217:00 amRNSTrading Update
7th Apr 20215:09 pmRNSHolding(s) in Company
31st Mar 20215:00 pmRNSTotal Voting Rights
4th Mar 20217:00 amRNSHolding(s) in Company
3rd Mar 20217:00 amRNSHolding(s) in Company
2nd Mar 20217:00 amRNSHolding(s) in Company
24th Feb 20213:55 pmRNSExercise of options and Director dealings
22nd Feb 20217:00 amRNSExercise of options and Director dealings
9th Feb 20214:35 pmRNSPrice Monitoring Extension
8th Feb 20217:00 amRNSTrading Update
18th Dec 20207:00 amRNSHalf-year Report
25th Nov 20209:53 amRNSResult of Annual General Meeting
25th Nov 20207:00 amRNSAGM statement and Trading Update
2nd Nov 20202:01 pmRNSPosting of Annual Report & Notice of AGM
15th Oct 20207:00 amRNSFinal Results
28th Sep 20207:00 amRNSTrading update and extension of results deadline
28th Aug 20205:15 pmRNSTotal Voting Rights
20th Aug 20202:05 pmRNSSecond Price Monitoring Extn
20th Aug 20202:00 pmRNSPrice Monitoring Extension
20th Aug 20201:18 pmRNSHolding(s) in Company
20th Aug 20208:01 amRNSCompletion of banking facilities & trading update
10th Aug 202011:05 amRNSSecond Price Monitoring Extn
10th Aug 202011:00 amRNSPrice Monitoring Extension
6th Aug 20208:41 amRNSResult of fundraise & Director shareholdings
6th Aug 20207:00 amRNSTrading update and proposed fundraise
30th Apr 20204:35 pmRNSPrice Monitoring Extension
23rd Mar 20207:00 amRNSTrading update
17th Mar 202011:06 amRNSSecond Price Monitoring Extn
17th Mar 202011:00 amRNSPrice Monitoring Extension
16th Mar 20202:05 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.